1. Sustained suppression of testosterone production by the luteinizing hormone releasing hormone agonist buserelin in patients with advanced prostatic carcinoma: a new therapeutic approach;Borgmann, V.; Hardt, W.; Schmidt-Gollwitzer, M.; Adenauer, H.; Nagel, R.;Lancet,1982
2. TIreatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer;Waxman, J.H.; Wass, J.A.H.; Hendry, W.F.;BrMedJ,1983
3. Leuprolide versus diethylstilbestrol for metastatic prostatic cancer;Group, Leuprolide Study;N EnglJ Med,1984
4. New approach in the treatment of prostatic cancer: complete instead of partial withdrawal of androgens;Labrie, F.; Dupont, A.; Belanger, A.; etal;Prostate,1983
5. Prognostic value of IgA rheumatoid factor;Ann Rheum Dis,1984